Newsroom

Press Release - All

• 02 Dec 2020
  Agilent Announces New, Innovative 7850 ICP-MS System
• 30 Nov 2020
  Agilent Announces Launch of Global Biomarker Pathologist Training Program
• 23 Nov 2020
  Agilent Reports Fourth-Quarter and Fiscal Year 2020 Financial Results; Initiates Fiscal 2021 Guidance
• 23 Nov 2020
  Agilent Launches New NanoDis System for Nanoparticle Dissolution Testing
• 18 Nov 2020
  Agilent Increases Cash Dividend to 19.4 Cents per Share
• 17 Nov 2020
  Agilent Presents Thought Leader Award to Drs. Carl H. June and Michael Milone
• 13 Nov 2020
  Agilent Receives Expanded FDA Approval for PD-L1 IHC 22C3 pharmDx in Triple-Negative Breast Cancer
• 04 Nov 2020
  Agilent Collaborates with SGS to Release New US EPA Method for the Analysis of Dioxins Using GC/TQ
• 02 Nov 2020
  Agilent Announces Memorandum of Understanding to Collaborate with GI Innovation for Biomarker Profiling in Phase 1/2 Study of Cancer Immunotherapy GI-101
• 29 Oct 2020
  Agilent to Webcast Fourth-Quarter Fiscal Year 2020 Financial Results Presentation, Sets Date for Virtual Analyst and Investor Meeting